157 related articles for article (PubMed ID: 37568378)
1. Long-Term Follow Up of Sexual Function and Steroid Levels in Women after Perimenopausal Hysterectomy with or without Concomitant Oophorectomy.
Zimmerman J; Brännström M; Bergdahl C; Aziz A; Hermansson J
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568378
[TBL] [Abstract][Full Text] [Related]
2. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being.
Aziz A; Brännström M; Bergquist C; Silfverstolpe G
Fertil Steril; 2005 Apr; 83(4):1021-8. PubMed ID: 15820815
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.
Wright JD; Silver ER; Tan SX; Hur C; Kastrinos F
JAMA Netw Open; 2021 Sep; 4(9):e2123616. PubMed ID: 34499134
[TBL] [Abstract][Full Text] [Related]
4. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
5. Comparison of female sexual function in women who underwent abdominal or vaginal hysterectomy with or without bilateral salpingo-oophorectomy.
Doğanay M; Kokanalı D; Kokanalı MK; Cavkaytar S; Aksakal OS
J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):29-32. PubMed ID: 30445203
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries.
Nunes E; Gallardo E; Morgado-Nunes S; Fonseca-Moutinho J
J Obstet Gynaecol; 2023 Dec; 43(1):2141618. PubMed ID: 36331514
[TBL] [Abstract][Full Text] [Related]
7. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
[TBL] [Abstract][Full Text] [Related]
10. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
12. Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study.
Everhov ÅH; Flöter Rådestad A; Nyberg T; Smedby KE; Bergmark K; Lindén Hirschberg A
J Sex Med; 2016 Mar; 13(3):413-24. PubMed ID: 26843116
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality.
Aziz A; Bergquist C; Nordholm L; Möller A; Silfverstolpe G
Maturitas; 2005 Aug; 51(4):349-57. PubMed ID: 16039407
[TBL] [Abstract][Full Text] [Related]
15. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
17. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835
[TBL] [Abstract][Full Text] [Related]
18. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
[TBL] [Abstract][Full Text] [Related]
19. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
20. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
Wilson LF; Pandeya N; Byles J; Mishra GD
Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
